Abstract
Bullous pemphigoid (BP) is an acquired blistering disease of the elderly with a substantially lower mortality than pemphigus vulgaris (PV). It is characterized histologically by subepidermal bullae and immunopathologically by in vivo deposition of autoantibodies and complement components along the epidermal basement membrane zone (BMZ). The majority of these patients also have circulating autoantibodies directed against the BMZ of stratified squamous epithelium. Because of these characteristics, BP is felt to be an autoimmune disease in which the cutaneous lesions may result as a consequence of these anti-BMZ antibodies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Lever, W. F. (1953) Pemphigus. Medicine, 32, 1–123.
Jordon, R. E., Beutner, E. H., Witebsky, E., et al. (1967) Basement zone antibodies in bullous pemphigoid. J. Amer. Med. Assoc., 200, 751–8.
Rook, A., Wilkinson, D. S. and Ebling, F. J. G. (eds) (1979) Textbook of Dermatology, Blackwell Scientific Publications, Oxford, pp. 1462–5.
Grattan, C. E. H. (1985) Evidence of an association between bullous pemphigoid and psoriasis. Brit. J. Dermatol., 113, 281–3.
Bean, S. F. (1987) in Clinics in Dermatology: Bullous Pemphigoid, Vol. 5 (ed. A.R. Ahmed), J. B. Lippincott, Philadelphia, pp. 13–17.
Marsden, R. A., McKee, P. H., Bhogal, B., et al. (1980) A study of benign chronic bullous dermatosis of childhood and comparison with dermatitis herpetiformis and bullous pemphigoid occurring in childhood. Clin. Exp. Dermatoi., 5, 159–72.
Lim, C. C., MacDonald, R. H. and Rook, A. J. (1968) Pemphigoid eruptions in the elderly. Trans. St. Johns Hosp. Dermatol. Soc. Lond., 54, 148–51.
Ahmed, A. R. and Newcomer, V. D. (1987) in Clinics in Dermatology: Bullous Pemphigoid (ed. A. R. Ahmed), J. B. Lippincott, Philadelphia, pp. 6–12.
Ahmed, A. R., Cohen, E., Blumenson, L. E. and Provost, T. T. (1977) HLA in Bullous Pemphigoid. Arch. Dermatol., 113, 1121.
Ahmed, A. R., Konqui, A., Park, M. S., Tiwari, J. L. and Terasaki, P. I. (1984) DR antigens in bullous pemphigoid. Arch. Dermatol., 120, 795.
Downham, T. F. and Chapel, T. A. (1978) Bullous pemphigoid therapy in patients with and without diabetes mellitus. Arch. Dermatol., 114, 1639–42.
Provost, T.T., Maiz, J.C., Ahmed, A.R., Strauss, J.S. and Dobson, R.L. (1979) Unusual subepidermal bullous diseases With immunologic features of bullous pemphigoid. Arch. Dermatol., 115, 156–60.
Jordon, R.E. (1987) in Dermatology in General Medicine (eds T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedberg and K.F. Austen), McGraw-Hill, New York, pp. 580–6.
Sison-Fonacier, L. and Bystryn, J.C. (1986) Regional variations in antigenic properties of skin. A possible cause for disease-specific distribution of skin lesions. J. Exp. Med., 164, 2125–30.
Venning, V.A., Frith, P.A., Bron, A.J., Millard, P.R. and Wojnarowska, F. (1988) Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Brit. J. Dermatol., 118, 7–15.
Lever, W. F. (1965) Pemphigus and Pemphigoid, Charles C. Thomas, Springfield, IL, p. 222.
Ahmed, A.R., Maize, J.C. and Provost, T.T. (1977) Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch. Dermatol., 113, 1043–6.
Person, J.R. and Rogers, R.S. (1977) Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations. Mayo Clin. Proc., 52, 54–66.
Perry, H.O. (1967) Skin disease with mucocutaneous involvement. Oral Surg., 24, 800.
Korman, N. (1987) Bullous pemphigoid. J. Amer. Acad. Dermatol., 16, 907–24.
Bingham, E.A., Burrow, D. and Sanford, J.C. (1984) Prolonged pruritus and bullous pemphigoid. Clin. Exp. Dermatol., 9, 564–70.
Gruber, G.G., Owen, L.G. and Callen, J.P. (1980) Vesicular pemphigoid. Amer. Acad. Dermatol., 3, 619–22.
Bean, S.F., Michel, B., Furey, N., Thorne, E.G. and Meltzer, L. (1976) Vesicular pemphigoid. Arch. Dermatol., 112, 1402–4.
Honeyman, J.F., Honeyman, A.R., De la Parra, M.A., Pinto, A. and Eguiguren, G.J. (1979) Polymorphic pemphigoid. Arch. Dermatol., 115, 423–7.
Al-Najjar, A., Reilly, G.D. and Bleehen, S.S. (1984) Pemphigoid vegetans: A case report. Acta Dermatol. Venereol., 64, 450–2.
Winkelmann, R.K. and Daniel Su, W.P. (1979) Pemphigoid vegetans. Arch. Dermatol., 115, 446–8.
Kuokkanen, K. and Helin, H. (1981) Pemphigoid vegetans. Report of a case. Arch. Dermatol., 117, 56.
Yung, C.W., Soltam, K. and Lorincz, A.L. (1981) Pemphigoid nodularis. Amer. Acad. Dermatol., 5, 54–60.
Massa, C. and Connolly, S.M. (1982) Bullous pemphigoid with features of prurigo nodularis. Arch. Dermatol., 118, 937–9.
Shornick, J.K., Banger, J.L., Freeman, R.G., et al. (1983) Herpes gestationis: clinical and histologie features of 28 cases. J. Amer. Acad. Dermatol., 8, 214–24.
Katz, S.I., Hertz, K.C. and Yaoita, H. (1976) Herpes gestationis: immunopathology and characterization of the HG factor. J. Clin. Invest., 57, 1434–41.
Katz, S. I. and Provost, T. T. (1987) in Dermatology in General Medicine, (eds T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedberg and K.F. Austen), McGraw Hill, New York, pp. 586–9.
Hardy, K.M., Perry, H.O., Pingree, G.C., Kirby, T.J. and Minn, R. (1971) Benign mucous membrane pemphigoid. Arch. Dermatol., 104, 467–73.
Lever, W.F. (1979) Pemphigus and pemphigoid. Amer. Acad. Dermatol., 1, 1–32.
Shklar, G. and McCarthy, P.L. (1971) Oral lesions of mucous membrane pemphigoid. A study of 85 cases. Arch. Otolaryngol., 93, 354–64.
Liu, H. N., Daniel Su, W.P. and Rogers, R.S. (1986) Clinical variants of pemphigoid. Int. J. Dermatol., 17–27.
Fine, J.D., Neises, G.R. and Katz, S.I. (1984) Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. J. Invest. Dermatol., 82, 39–43.
Roenigk, H., Ryan, J.G. and Bergfeld, W.F. (1971) Epidermolysis bullosa acquisita. Arch. Dermatol., 103, 1–10.
Gammon, W.R., Briggaman, R.A., Woodley, D.T., Heald, P.W. and Wheeler, C.E. (1984) Epidermolysis bullosa acquisita — a pemphigoidlike disease. J. Amer. Acad. Dermatol., 11, 820–32.
Briggaman, R.A., Gammon, W.R. and Woodley, D.T. (1985) Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J. Invest. Dermatol., 85, 79s–84s.
Lawley, T. J., Strober, W., Yaoita, H. and Katz, S.I. (1980) Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits. J. Invest. Dermatol., 74, 9–12.
Yaoita, H. and Katz, S.I. (1977) Circulating IgA antibasement membrane zone antibodies in dermatitis herpetiformis. J. Invest. Dermatol., 69, 558–60.
Chorzelski, T.P., Jablonska, S., Beutner, E.H., et al. (1987) in Immunopathology of the Skin (eds E.H. Beutner, T.P. Chorzelski and V. Kumar), John Wiley and Sons, New York, pp. 407–20.
Leonard, J.N., Haffenden, G.P., Ring, NP., et al. (1982) Linear IgA disease in adults. Brit. J. Dermatol., 107, 301–16.
Camisa, C. and Sharma, H.M. (1983) Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature. J. Amer. Acad. Dermatol., 9, 924–32.
Olansky, A.J., Briggaman, R.A., Gammon, W.R., Kelly, T.F. and Sams, W.M. (1982) Bullous systemic lupus erythematosus. J. Amer. Acad. Dermatol., 7, 511–20.
Fellner, MJ. and Katz, J.M. (1976) Occurrence of bullous pemphigoid after furosemide therapy. Arch. Dermatol., 112, 75–7.
Bean, S.F., Good, R.A. and Windhorst, D.B. (1970) Bullous pemphigoid in an 11-year-old boy. Arch. Dermatol., 102, 205–8.
Fincher, D.F., Dupree, E., Tex, G. and Bean, S.F. (1971) Bullous pemphigoid in childhood. Immunofluorescent studies. Arch. Dermatol., 103, 88–90.
Bart, B.J. and Bean, S.F. (1970) Bullous pemphigoid following the topical use of fluorouracil. Arch. Dermatol., 102, 457–9.
Flotte, T.J. (1987) in Clinics in Dermatology: Bullous Pemphigoid (ed. A.R. Ahmed), J.B. Lippincott, Philadelphia, pp. 71–80.
Lever, W.F. and Schaumburg-Lever, G. (1983) Histopathology of the Skin, J.B. Lippincott, Philadelphia, pp. 113–17.
Imber, M.J., Murphy, G.F. and Jordon, R.E. (1987) in Clinics in Dermatology: Bullous Pemphigoid (ed. A.R. Ahmed), J.B. Lippincott, Philadelphia, pp. 81–92.
Gammon, W.R. (1987) in Immunopathology of the Skin (eds E.H. Beutner, T.P. Chorzelski and V. Kumar), John Wiley and Sons, New York, pp. 323–36.
Jordon, R.E. (1975) Complement activation in bullous skin diseases. J. Invest. Dermatol., 65, 162–9.
Nieboer, C. and van Leeuwen, J.E. (1980) IgE in the serum and on mast cells in bullous pemphigoid. Arch. Dermatol., 116, 555–6.
Baba, T., Sonozaki, H., Seki, K., et al. (1976) An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients. J. Immunol., 116, 112–16.
Herrmann, K., Lohrisch, I., Böhme, H.J. and Haustein, U.F. (1978) Detection of antibodies after immune complex splitting in serum of patients with bullous pemphigoid and systemic lupus erythematosus. Brit. J. Dermatol., 99, 635–40.
Danno, K., Okamoto, H., Miyauchi, H. and Imamura, S. (1982) Bullous pemphigoid and antinuclear antibodies. Unmasking of basement membrane fluorescence in sodium chloride-treated substrates. Arch. Dermatol., 118, 37–9.
Millns, J.L., Meurer, M. and Jordon, R.E. (1979) The complement system in bullous pemphigoid. VI. C3 fixing activity in the absence of detectable antibody. Clin. Immunol. Immunopathol., 13, 475.
Chorzelski, T.P. and Beutner, E.H. (1972) Factors contributing to occasional failures in the laboratory diagnosis of bullous pemphigoid by indirect immunofluorescence. Brit. J. Dermatol., 86, 111–17.
Zhu, X.J. and Bystryn, J.C. (1983) Heterogeneity of pemphigoid antigens. J. Invest. Dermatol., 80, 16–20.
Kelly, S. E. and Wojnarowska, F. (1988) The use of chemically split tissue in the deletion of circulating anti-basement zone antibodies in bullous pemphigoid. Brit. J. Dermatol., 118, 31–40.
Gammon, W.R., Briggaman, R.A., Inman, A.O., et al. (1984) Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J. Invest. Dermatol., 82, 139–44.
Logan, R.A., Bhogal, B., Das, A.K., McKee, P.M. and Black, M.M. (1987) Localization of bullous pemphigoid antibody — an indirect study of 228 cases using a split-skin technique. Brit. J. Dermatol., 117, 471–8.
Ullman, S., Halberg, P. and Nielsen, R. (1975) Anti-basement membrane antibodies in sera from patients without bullous pemphigoid. Acta Dermatovenereol., 55, 305–8.
Arbesman, C.E., Eypych, J.I., Reisman, R.E., et al., (1974) IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch. Dermatol., 110, 378–81.
Sushkell, L.L. and Jordon, R.E. (1983) Bullous pemphigoid: a cause of peripheral blood eosinophilia. J. Amer. Acad. Dermatol., 8, 648–51.
Jordon, R.E., Muller, S.A., Minn, R., Hale, W.L. and Beutner, E.H. (1969) Bullous pemphigoid associated with systemic lupus erythematosus. Arch. Dermatol., 99, 17–25.
Stoll, D.M. and King, Jr. L.E. (1984) Association of bullous pemphigoid with systemic lupus erythematosus. Arch. Dermatol., 120, 362–6.
Pedro, S.D., Tex, L. and Dahl, M.V. (1973) Direct immunofluorescence of bullous systemic lupus erythematosus. Arch. Dermatol., 107, 118–20.
Gammon, W.R. and Lewis, D.M. (1986) Bullous eruption of system lupus erythematosus. Curr. Concepts Skin Disorders, 7, 5–9.
Gammon, W.R., Woodley, D.T., Dole, K.C. and Briggaman, R.A. (1985) Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J. Invest. Dermatol., 84, 472–6.
Chuang, T.Y., Korkij, W., Soltani, K., Clayman, J. and Cook, J. (1984) Increased frequency of diabetes mellitus in patients with bullous pemphigoid: A case-control study. J. Amer. Acad. Dermatol., 11, 1099–102.
Koerber, W.A., Price, N.M. and Watson, W. (1978) Coexistent psoriasis and bullous pemphigoid. Arch. Dermatol., 114, 1643–6.
Person, J.R. and Rogers, R.S. (1976) Bullous pemphigoid and psoriasis: does subclinical bullous pemphigoid exist? Brit. J. Dermatol., 95, 535–40.
Robinson, J.K., Baughman, R.D. and Provost, T.T. (1978) Bullous pemphigoid induced by PUVA therapy. Is this the aetiology of the acral bullae produced during PUVA treatment? Brit. J. Dermatol., 99, 709–13.
Cram, D.L. and Fukuyama, K. (1972) Immunohistochemistry of ultraviolet-induced pemphigus and pemphigoid lesions. Arch. Dermatol., 106, 819–24.
Callen, J.P. (1980) Internal disorders associated with bullous disease of the skin. Amer. Acad. Dermatol., 3, 107–19.
Giannini, J.M., Callen, J.P. and Gruber, G.G. (1981) Bullous pemphigoid and rheumatoid arthritis. Amer. Acad. Dermatol., 4, 695–7.
Savin, J.A. (1979) The events leading to the death of patients with pemphigus and pemphigoid. Brit. J. Dermatol., 101, 521–6.
Salo, O.P. and Rasanen, J.S. (1972) Pemphigoid and rheumatoid arthritis. Ann. Clin. Res., 4, 173–7.
Chorzelski, T.P., Jablonska, S., Beutner, E.H., et al. (1987) in Immunopathology of the Skin (eds E.H. Beutner, T.P. Chorzelski and V. Kumar), John Wiley and Sons, New York, pp. 337–54.
Lang, P.G. and Maize, J.C. (1983) Coexisting lichen planus and bullous pemphigoid or lichen planus pemphigoides? J. Amer. Acad. Dermatol., 9, 133–40.
Mora, R.G., Nesbitt, L.T. and Brantley, J.B. (1983) Lichen planus pemphigoides: Clinical and immunofluorescent findings in four cases. J. Amer. Acad. Dermatol., 8, 331–6.
Prost, C., Tesserand, F., Laroche, L. et al. (1985) Lichen planus pemphigoides: an immuno-electron microscopic study. Brit. J. Dermatol., 113, 31–6.
Stingl, G. and Holubar, K. (1975) Coexistence of lichen planus and bullous pemphigoid. An immunopathological study. Brit. J. Dermatol., 93, 313–20.
Stanley, J.R., Hawley-Nelson, P., Yuspa, S.H., et al. (1981) Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell., 24, 897–903.
Stone, S.P. and Schroeter, A.L. (1975) Bullous pemphigoid and associated malignant neoplasms. Arch. Dermatol., 111, 991–4.
Ahmed, A.R., Chu, T.M. and Provost, T.T. (1977) Bullous pemphigoid. Clinical and sérologic evaluation for associated malignant neoplasms. Arch. Dermatol., 113, 969.
Paslin, D.A. (1973) Bullous pemphigoid and hypernephroma: a critical review of the association of bullous pemphigoid and malignancy. Oral Glucocorticoids, 14, 554–5.
Chorzelski, T.P., Jablonska, S., Maciejowska, E., et al. (1978) Coexistence of malignancies with bullous pemphigoid. Arch. Dermatol., 114, 964.
Hodge, L., Marsden, R.A., Black, M.M., et al. (1981) Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings. Brit.]. Dermatol., 105, 65–9.
Dahl, M.V. (1987) in Clinics in Dermatology: Bullous Pemphigoid (ed. A.R. Ahmed), J.B. Lippincott, Philadelphia, pp. 64–70.
Gammon, W.R., Merritt, C.C., Lewis, D.M., et al. (1982) An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J. Invest. Dermatol., 78, 285–90.
Anhalt, G.J., Bahn, C.F., Labib, R.S. et al. (1981) J. Clin. Invest., 68, 1097–101.
Diaz, L.A., Weiss, HJ., Calvanico, N.J., et al. (1978) Phylogenetic studies with pemphigus and pemphigoid antibodies. Acta Dermatol. Venereol., 58, 537–40.
Beutner, E.H., Jordon, R.E. and Chorzelski, T.P. (1968) The immunopathology of pemphigus and bullous pemphigoid. J. Invest. Dermatol., 51, 63–80.
Woodley, D., Didierjean, L., Régnier, M. et al. (1980) Bullous pemphigoid antigen synthesized in vitro by human epidermal cells. J. Invest. Dermatol., 75, 148–51.
Stanley, J.R., Hawley-Nelson, P., Poirier, M., et al. (1980) Detection of pemphigoid antigen, pemphigus antigen, and keratin filaments by indirect immunofluorescence in cultured human epidermal cells. J. Invest. Dermatol., 75, 183–6.
Holubar, K., Wolff, K., Konrad, K. and Beutner, E.H. (1975) Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. J. Invest. Dermatol., 64, 220–7.
Schaumburg-Lever, G., Rule, A., Schmidt-Ullrich, B. and Lever, W.F. (1975) Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid — a preliminary report. J. Invest. Dermatol., 64, 47–9.
Pehamberger, H., Gschnait, F., Konrad, K., et al. (1980) Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: circulating anti-basement membrane zone. J. Invest. Dermatol., 74, 105–8.
Mutasim, D.F., Takahashi, Y., Labib, R.S., et al. (1985) A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J. Invest. Dermatol., 84, 47–53.
Regnier, M., Vaigot, P., Michel, S. and Prunieras, M. (1985) Localization of bullous pemphigoid antigen (BPA) in isolated human keratinocytes. J. Invest. Dermatol., 85, 187–90.
Westgate, G.E., Weaver, A.C. and Couchman, J.R. (1985) Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes. J. Invest. Dermatol., 84, 218–24.
Takahashi, Y., Mutasim, D.F., Patel, H.P., et al. (1985) The use of human pemphigoid autoantibodies to study the fate of epidermal basal cell hemidesmosomes after trypsin dissociation. J. Invest. Dermatol., 85, 309–13.
Diaz, L.A., Calvanio, N.J., Tomasi, T.B. and Jordon, R.E. (1977) Bullous pemphigoid antigen: isolation from normal human skin. J. Immunol., 118, 455–60.
Stanley, J.R., Woodley, D.T. and Katz, S.I. (1984) Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J. Invest. Dermatol., 82, 108–111.
Labib, R.S., Anhalt, G.J., Patel, H.P., et al. (1986) Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J. Immunol., 136, 1231–5.
Stanley, J.R., Alvarez, O.M., Bere, E.W., et al. (1981) Detection of basement membrane zone antigens during epidermal wound healing in pigs. J. Invest. Dermatol., 77, 240–3.
Hintner, H., Fritsch, P.O., Foidart, J.M., et al. (1980) Expression of basement membrane zone antigens at the dermoepibolic junction in organ cultures of human skin. J. Invest. Dermatol., 74, 200–4.
Stanley, J.R., Beckwith, J.B., Fuller, R.P., et al. (1982) A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors. Cancer, 50, 1486–90.
Gammon, W.R., Merritt, C.C., Lewis, D.M., et al. (1982) Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid. J. Invest. Dermatol., 78, 52–7.
Naito, K., Morioka, S., Ikeda, S. and Ogawa, H. (1984) Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement, and migrating cells. J. Invest. Dermatol., 82, 227–30.
Gammon, R.W. and Briggaman, R.A. (1987) Absence of specific changes in guinea pig skin treated with bullous pemphigoid antibodies. Clin. Res., 35, 388A.
Jordon, R.E., Nordby, J.M. and Milstein, H. (1975) The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J. Lab. Clin. Med., 86, 733–40.
Jordon, R.E., Sams, W.M. and Beutner, E.H. (1969) Complement immunofluorescent staining in bullous pemphigoid. J. Lab. Clin. Med., 74, 548–56.
Sams, W.M. and Schur, P.H. (1973) Studies of the antibodies in pemphigoid and pemphigus. J. Lab. Clin. Med., 82, 249–254.
Bird, P., Friedmann, P.S., Ling, N., et al. (1986) Subclass distribution of IgG autoantibodies in bullous pemphigoid. J. Invest. Dermatol., 86, 21–5.
Nakagawa, T. and DeWeck, A.L. (1983) Membrane receptors for the IgG4 subclass on human basophils and mast cells. Clin. Rev. Allergy, 1, 197–206.
Schmidt-Ullrich, B., Rule, A., Schaumburg-Lever, G. and Leblanc, C. (1975) Ultrastructural localization of in vivo-bound complement in bullous pemphigoid. J. Invest. Dermatol., 65, 217–19.
Jordon, R.E., Day, N.K., Sams, W.M. and Good, R.A. (1973) The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J. Clin. Invest., 52, 1207–14.
Jordon, R.E., Kawana, S. and Fritz, K.A. (1985) Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J. Invest. Dermatol., 85, 72s–8s.
Dahl, M.V., Falk, R.J., Carpenter, R. and Michael, A.F. (1984) Deposition of the membrane attack complex of complement in bullous pemphigoid. J. Invest. Dermatol., 82, 132–5.
Wintroub, B.U., Mihm, M.C., Goetzl, E.J., et al. (1978) Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. New England]. Med., 298, 417–21.
Katayama, I., Doi, T. and Nishioka, K. (1984) High histamine level in the blister fluid of bullous pemphigoid. Arch. Dermatol. Res., 276, 126–7.
Dvorak, A.M., Mihm, M.C., Osage, J.E., et al. (1982) Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J. Invest. Dermatol., 78, 91–101.
Dubertret, L., Bertaux, B., Fosse, M. and Touraine, R. (1980) Cellular events leading to blister formation in bullous pemphigoid. Brit. J. Dermatol., 104, 615–24.
Sams, W.M. and Gammon, W.R. (1982) Mechanism of lesion production in pemphigus and pemphigoid. J. Amer. Acad. Dermatol., 6, 431–49.
Savin, J.A. (1987) in Clinics in Dermatology: Bullous Pemphigoid (ed. A.R. Ahmed), J.B. Lippincott, Philadelphia, pp. 52–9.
Ahmed, A.R. and Rogers, R.S. (1987) in Clinics in Dermatology: Bullous Pemphigoid (ed. A.R. Ahmed), J.B. Lippincott, Philadelphia, pp. 146–54.
Church, R. (1960) Pemphigoid treated with corticosteroids. Brit. J. Dermatol., 72, 431–41.
Gallant, C. and Kenny, P. (1986) Oral gluco corticoids and their complications. J. Amer. Acad. Dermatol., 14, 161–75.
Greaves, M.W., Burton, J.L., Marks, J. and Dawber, R.P.R. (1971) Azathioprine in treatment of bullous pemphigoid. Brit. Med. J., 1, 144–5.
Burton, J.L. and Greaves, M.W. (1974) Azathioprine for pemphigus and pemphigoid-a 4 year follow-up. Brit. J. Dermatol., 91, 103–9.
Ahmed, A.R. and Moy, R. (1981) Azathioprine. Int. J. Dermatol., 20, 461–9.
Krain, L.S., Landau, J.W. and Newcomer, V.D. (1972) Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Arch. Dermatol., 106, 657–61.
Ahmed, A.R. and Hombal, S.M. (1984) Cyclophosphamide review of relevant pharmacology and clinical uses. J. Amer. Acad. Dermatol., 6, 1115–26.
Person, J.R. and Rogers, III, R.S. (1977) Bullous pemphigoid responding to sulfapyridine and the sulfones. Arch. Dermatol., 113, 610–15.
Rook, A. and Waddington, E. (1953) Pemphigus and pemphigoid. Brit. J. Dermatol., 65, 425–31.
Siegel, J. and Eaglstein, W.H. (1984) High-dose methylprednisolone in the treatment of bullous pemphigoid. Arch. Dermatol., 120, 1157–65.
Goldberg, N.S., Robinson, J.K., Roenigk, Jr., H.H., et al. (1985) Plasmapheresis therapy for bullous pemphigoid. Arch. Dermatol., 121, 1484–5.
Roujeau, J.C., Morel, P., Dalle, E., et al. (1984) Plasma exchange in bullous pemphigoid. Lancet, ii, 486–9.
Thivolet, J., Barthélémy, H., Rigot-Muller, G. and Bendelac, A. (1985) Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet, i, 334–5.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Morrison, L.H., Diaz, L.A., Anhalt, G.J. (1990). Bullous pemphigoid. In: Wojnarowska, F., Briggaman, R.A. (eds) Management of Blistering Diseases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7190-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7190-6_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-28990-3
Online ISBN: 978-1-4899-7190-6
eBook Packages: Springer Book Archive